Literature DB >> 31205169

Novel Application of the Pfirrmann Disc Degeneration Grading System to 9.4T MRI: Higher Reliability Compared to 3T MRI.

Idrees Sher1,2,3, Chris Daly1,2,3, David Oehme4, Ronil V Chandra2,5, Mustafa Sher6, Peter Ghosh3,7, Julian Smith2, Tony Goldschlager1,2,3.   

Abstract

STUDY
DESIGN: Reliability study.
OBJECTIVE: To evaluate the applicability and reliability of 9.4T magnetic resonance imaging (MRI) in the assessment of degenerative disc disease compared with 3T MRI. SUMMARY OF BACKGROUND DATA: MRI is a reliable indicator of biochemical changes in the intervertebral disc (IVD) including hydration status, proteoglycan content, and disc degeneration compared with anatomical and histological studies. High-field 9.4T MRI has been shown to provide superior resolution and anatomical detail. However, it has not been tested against current standard MRI techniques.
METHODS: Disc degeneration was initiated in 36 skeletally mature ewes 6 months prior to necropsy via validated surgical IVD injury models using either scalpel injury or drill-bit injury techniques at lumbar spine levels L2/3 and L3/4 with L1/2, L4/5, and L5/6 serving as control discs. All ex vivo IVDs were examined with 9.4T MRI and 3T MRI. All scans were analyzed using the Pfirrmann grading system by four independent observers. Intra- and interobserver reliability was assessed using kappa statistics and Spearman correlation.
RESULTS: Inter- and intraobserver agreement for 9.4T MRI was excellent, both at κ 0.91 (P < 0.001). Comparatively, 3T interobserver reliability demonstrated substantial agreement at κ 0.61 (P < 0.001). Complete agreement was obtained in 92.7% to 100% of discs at 9.4T compared with 69.7% to 83.1% at 3T. A difference of one grade or more occurred in 6.7% at 9.4T and 39.3% at 3T. 9.4T MRI scored 97.3% of discs as grade 1 to 2 compared with 71.3% at 3T. 3T MRI tended to over-score the extent of disc degeneration with 28.6% of discs scored as grade 3 or higher compared with 2.7% at 9.4T MRI.
CONCLUSION: 9.4T MRI study of IVD degeneration using the Pfirrmann grading system demonstrated excellent inter- and intraobserver reliability. Comparatively, 3T MRI demonstrated a tendency to over score the extent of disc degeneration. This improved reliability of 9.4T MRI holds great potential for its clinical applications. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2019        PMID: 31205169     DOI: 10.1097/BRS.0000000000002967

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Feasibility of Deep Learning Algorithms for Reporting in Routine Spine Magnetic Resonance Imaging.

Authors:  Kai-Uwe LewandrowskI; Narendran Muraleedharan; Steven Allen Eddy; Vikram Sobti; Brian D Reece; Jorge Felipe Ramírez León; Sandeep Shah
Journal:  Int J Spine Surg       Date:  2020-12

2.  Application study of 3D LAVA-Flex on lumbar intervertebral disc degeneration.

Authors:  Tiefang Liu; Yonghao Wang; Zhengyang Xu; Tao Wu; Xiao Zang; Meng Li; Jinfeng Li
Journal:  Eur J Med Res       Date:  2021-05-07       Impact factor: 2.175

3.  Gene-Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus.

Authors:  Wei Chen; Hao Chen; Dandan Zheng; Hongbo Zhang; Lianfu Deng; Wenguo Cui; Yuhui Zhang; Hélder A Santos; Hongxing Shen
Journal:  Adv Sci (Weinh)       Date:  2019-10-07       Impact factor: 16.806

Review 4.  Imaging Evaluation of Intervertebral Disc Degeneration and Painful Discs-Advances and Challenges in Quantitative MRI.

Authors:  Shota Tamagawa; Daisuke Sakai; Hidetoshi Nojiri; Masato Sato; Muneaki Ishijima; Masahiko Watanabe
Journal:  Diagnostics (Basel)       Date:  2022-03-14

5.  A comprehensive tool box for large animal studies of intervertebral disc degeneration.

Authors:  Naomi N Lee; Elias Salzer; Frances C Bach; Andres F Bonilla; James L Cook; Zulma Gazit; Sibylle Grad; Keita Ito; Lachlan J Smith; Andrea Vernengo; Hans-Joachim Wilke; Julie B Engiles; Marianna A Tryfonidou
Journal:  JOR Spine       Date:  2021-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.